AI Science Tracker
EN

AI imaging measures change during cardiac amyloidosis treatment

Medical University of Vienna; University Hospital Essen · 29 Nov 2025 · medicine

Discovery

AI imaging measures change during cardiac amyloidosis treatment

Source check: Source checked. Not independent scientific confirmation.

Finding: Automated cardiac segmentation quantified serial SPECT/CT scans in 45 patients receiving transthyretin amyloidosis therapies. Several tracer-uptake markers decreased after treatment, and selected changes were associated with functional measures. These exploratory observational results do not prove treatment causality or removal of amyloid deposits; affected-volume measures did not significantly decline.

Technology: TotalSegmentator; foundational deep-learning CT segmentation

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
A pretrained anatomical segmentation network maps cardiac structures to SPECT, enabling standardized regional tracer measurements over time.
Test and result
Serial baseline/follow-up clinical imaging, automated cardiac-region quantification and exploratory associations with functional measurements.
Limitation / still unknown
Controlled treatment effects, cross-scanner generalizability and clinical decision benefit remain unestablished; the paper has inconsistent aggregate marker counts and small treatment subgroups.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://link.springer.com/article/10.1007/s00259-025-07673-6

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary relevant model Methods, Results and limitations; exact primary identity and current primary PubMed correction/retraction relationships checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.